Skip to main content
. 2022 Dec 12;7(1):24–37. doi: 10.1038/s41551-022-00969-0

Fig. 5. Combinatorial signal enhanced iCAR-TCTL anti-tumour function.

Fig. 5

a, Treatment schedule of the ovarian cancer peritoneal dissemination xenograft model. NSG mice were injected intraperitoneally with 5 × 105 KOC7c cells expressing luciferase. From the third day after the ovarian cancer inoculation, 1 × 106 iCAR-TCTL, DGK-dKO-iCAR-TCTL, iCAR-TCTL-mbIL15tg, DGK-dKO-iCAR-TCTL-mbIL15tg, pCAR-TCTL or DGK-pKO-pCAR-TCTL-mbIL15tg were injected intraperitoneally (n = 5 for each group). b, In vivo bioluminescence imaging of Renilla luciferase-labelled KOC7c. c, Survival of treated mice at the indicated timepoints after the injection. log-rank test with Bonferroni multiple comparisons test. d, In vivo bioluminescence imaging of firefly luciferase-labelled injected CAR-T cells in NSG mice. e, Total flux (photons s−1) of injected CAR-T cells at the indicated timepoints. One-way ANOVA with Tukey’s multiple comparisons test.